Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...
In letters to the respective states warning of the upcoming layoffs, CVS signaled its plans to cut more than 630 jobs at it's Woonsocket, Rhode Island, headquarters. Another 416 employees of the ...
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...
Medpage Today on MSN21h
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as DementiaAll doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback